Cannabichromene (CBC) is a non-psychoactive cannabinoid. Some pre-clinical evidence of anti-inflammatory and analgesic (pain-relief) potential has been observed. Because most studies are pre-clinical, we don’t yet know optimal dosing, long-term safety, interactions, or whether results in humans will replicate the animal/lab findings.

CBC is great for improving brain cell functions and depression. This cannabinoid can also be used to treat cancer patients. CBC is also known to work with THC in a yet unknown way to make the “high” more intense and pronounced. This minor cannabinoid plays a major part in the entourage effect of the full plant. This cannabinoid can also be used as a strong sedative and pain reliever.